Home » Topics » BioWorld Science

BioWorld Science
RSS

Idec begins phase I/II trial for 9-AC

Nov. 19, 1997

AMBI cleared by FDA to commence nisin trials

Nov. 19, 1997

Centocor's anti-TNF-alpha antibody closes fistulae in Crohn's patients

Nov. 19, 1997

Ono discloses novel NOS inhibitors with broad potential application

Nov. 19, 1997

Alza and SmithKline Beecham expand Nicoderm marketing agreement

Nov. 19, 1997

New antifungals from Pola

Nov. 19, 1997

Sankyo isolates A-76356, novel antibacterial agent

Nov. 19, 1997

FDA clears Plavix

Nov. 19, 1997

Modex Therapeutiques established as independent company; CytoTherapeutics reduces ownership

Nov. 19, 1997

Banyu describes protein farnesyltransferase inhibitors

Nov. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.